Cargando…

Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with abnormal protein modification, inflammation and memory impairment. Aggregated amyloid beta (Aβ) and phosphorylated tau proteins are medical diagnostic features. Loss of memory in AD has been associated with central...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitra, Sumonto, Behbahani, Homira, Eriksdotter, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370742/ https://www.ncbi.nlm.nih.gov/pubmed/30804738 http://dx.doi.org/10.3389/fnins.2019.00038

Ejemplares similares

Microglia Impairs Proliferation and Induces Senescence In-Vitro in NGF Releasing Cells Used in Encapsulated Cell Biodelivery for Alzheimer’s Disease Therapy
por: Mitra, Sumonto, et al.
Publicado: (2022)

Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to App(NL−G−F) knock-in Alzheimer mice
por: Tambaro, Simone, et al.
Publicado: (2023)

Amyloid-Beta Peptides and Activated Astroglia Impairs Proliferation of Nerve Growth Factor Releasing Cells In Vitro: Implication for Encapsulated Cell Biodelivery-Mediated AD Therapy
por: Mitra, Sumonto, et al.
Publicado: (2021)

Editorial: Neurotrophins Biodelivery to CNS: Innovative Approaches for Disease-Modifying Therapy
por: Triaca, Viviana, et al.
Publicado: (2022)

Fast Alpha Activity in EEG of Patients With Alzheimer’s Disease Is Paralleled by Changes in Cognition and Cholinergic Markers During Encapsulated Cell Biodelivery of Nerve Growth Factor
por: Eyjolfsdottir, Helga, et al.
Publicado: (2022)

ProNGF and Neurodegeneration in Alzheimer’s Disease
por: Fahnestock, Margaret, et al.
Publicado: (2019)

Increased Active OMI/HTRA2 Serine Protease Displays a Positive Correlation with Cholinergic Alterations in the Alzheimer’s Disease Brain
por: Darreh-Shori, Taher, et al.
Publicado: (2018)

Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?
por: Alastra, Giuseppe, et al.
Publicado: (2021)

Editorial: The Involvement of NGF in the Alzheimer's Pathology
por: Cuello, A. Claudio
Publicado: (2019)

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
por: Eyjolfsdottir, Helga, et al.
Publicado: (2016)

The Brain NGF Metabolic Pathway in Health and in Alzheimer’s Pathology
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Increased Endogenous GDNF in Mice Protects Against Age-Related Decline in Neuronal Cholinergic Markers
por: Mitra, Sumonto, et al.
Publicado: (2021)

Biodelivery of therapeutic extracellular vesicles: should mononuclear phagocytes always be feared?
por: Cieślik, Martyna, et al.
Publicado: (2023)

NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward
por: Malerba, Francesca, et al.
Publicado: (2016)

proNGF Measurement in Cerebrospinal Fluid Samples of a Large Cohort of Living Patients With Alzheimer's Disease by a New Automated Immunoassay
por: Malerba, Francesca, et al.
Publicado: (2021)

CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease
por: Karami, Azadeh, et al.
Publicado: (2019)

proNGF Involvement in the Adult Neurogenesis Dysfunction in Alzheimer’s Disease
por: Olabiyi, Bolanle Fatimat, et al.
Publicado: (2021)

Clinical translation of stem cell therapy in traumatic brain injury: the potential of encapsulated mesenchymal cell biodelivery of glucagon-like peptide-1
por: Heile, Anna, et al.
Publicado: (2011)

The Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor
por: Pandini, Giuseppe, et al.
Publicado: (2016)

Influence of Quadrato Motor Training on Salivary proNGF and proBDNF
por: Caserta, Micaela, et al.
Publicado: (2019)

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
por: Tikhonova, Maria A., et al.
Publicado: (2022)

Long-term, stable, targeted biodelivery and efficacy of GDNF from encapsulated cells in the rat and Goettingen miniature pig brain
por: Wahlberg, Lars U., et al.
Publicado: (2020)

ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics
por: Panahi, Mahmod, et al.
Publicado: (2023)

Association of TrkA and APP Is Promoted by NGF and Reduced by Cell Death-Promoting Agents
por: Canu, Nadia, et al.
Publicado: (2017)

Multivesicular bodies mediate long-range retrograde NGF-TrkA signaling
por: Ye, Mengchen, et al.
Publicado: (2018)

Getting ahead of Alzheimer’s disease: early intervention with focused ultrasound
por: Noel, Rebecca L., et al.
Publicado: (2023)

Spinal Mobilization Prevents NGF-Induced Trunk Mechanical Hyperalgesia and Attenuates Expression of CGRP
por: Reed, William R., et al.
Publicado: (2020)

Editorial: Experimental and innovative approaches to multi-target treatment of Parkinson's and Alzheimer's diseases - Volume II
por: Tikhonova, Maria A., et al.
Publicado: (2023)

NGF-Dependent Changes in Ubiquitin Homeostasis Trigger Early Cholinergic Degeneration in Cellular and Animal AD-Model
por: Latina, Valentina, et al.
Publicado: (2018)

Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Systemic L-Buthionine -S-R-Sulfoximine Treatment Increases Plasma NGF and Upregulates L-cys/L-cys2 Transporter and γ-Glutamylcysteine Ligase mRNAs Through the NGF/TrkA/Akt/Nrf2 Pathway in the Striatum
por: Valdovinos-Flores, Cesar, et al.
Publicado: (2019)

Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons
por: Latina, Valentina, et al.
Publicado: (2017)

The Intersection of NGF/TrkA Signaling and Amyloid Precursor Protein Processing in Alzheimer’s Disease Neuropathology
por: Canu, Nadia, et al.
Publicado: (2017)

Age-induced nitrative stress decreases retrograde transport of proNGF via TrkA and increases proNGF retrograde transport and neurodegeneration via p75(NTR)
por: Kropf, Erika, et al.
Publicado: (2023)

NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease
por: Triaca, Viviana, et al.
Publicado: (2016)

Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapies
por: Zha, Kangkang, et al.
Publicado: (2021)

Astrocyte adaptation in Alzheimer’s disease: a focus on astrocytic P2X(7)R
por: Beltran-Lobo, Paula, et al.
Publicado: (2023)

Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
por: García, Octavio, et al.
Publicado: (2022)

Ophthalmic Biomarkers for Alzheimer’s Disease: A Review
por: Majeed, Ayesha, et al.
Publicado: (2021)

Effects of Red Liriope platyphylla on NGF secretion ability, NGF receptor signaling pathway and γ-secretase components in NSE/hAPPsw transgenic mice expressing Alzheimer's Disease
por: Choi, Sun-Il, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0374cot5d3rfplgr43tp4rtadb